Two antigens (n = 2/50, PLEKHA8 and PRM2) showed abundant uniform reactivity across all healthy, all benign and virtually all cancer samples (n = 78/80, n = 79/80 respectively) and were excluded from subsequent analyses. This evidence concerns the gene PRM2 and cancer.